Results 131 to 140 of about 47,798 (276)

Do LORIS trial eligibility criteria identify a ductal carcinoma in situ (DCIS) patient population at low risk of upgrade to invasive carcinoma?

Annals of Surgical Oncology, 2016
BackgroundThe Surgery Versus Active Monitoring for Low-Risk DCIS (LORIS) trial is studying the safety of monitoring core-biopsy diagnosed low-risk ductal carcinoma in situ (DCIS) without excision.
M. Pilewskie, M. Stempel, H. Rosenfeld, A. Eaton, K. V. Van Zee, M. Morrow   +5 more
semanticscholar   +1 more source

MDCT Is Very Useful for Evaluating the Spread of DCIS.

, 2009
Introduction: Ductal carcinoma in situ (DCIS) may occasionally spread widely in the duct-lobular segment, thereby complicating the complete resection of the lesion in breast-conserving surgery.
K. Yoshida, H. Takayanagi, I. Kimijima
core   +1 more source

DCIS growth.

, 2018
The deterministic and stochastic necrosis models both result in linear DCIS growth at approximately 1 cm/year (left), even while their cell counts differ by 21% by the end of the simulations (right).
Shannon M. Mumenthaler (752667), Paul Macklin (3475172), Randy Heiland (9979), Ahmadreza Ghaffarizadeh (3475166), Samuel H. Friedman (4884352)   +4 more
core   +1 more source

ALDH5A1 is over-expressed in DCIS models.

, 2012
Whole cell lysates from 3D rBM overlay cultures of MCF10A, MCF10.DCIS, SUM102 and SUM225 were probed for ALDH5A1 (upper panel) and for GAPDH (lower panel) as a loading control.
Stephen A. Krawetz (113433), Mansoureh Sameni (113429), Quanwen Li (113426), Bonnie F. Sloane (113436), Raymond R. Mattingly (113438), Shihong Mao (113422), Hitchintan Kaur (113418)   +6 more
core   +1 more source

Evaluation of intra-individual DCIS heterogeneity among patients (n = 36) concurrently diagnosed with IDC and DCIS.

, 2014
(A) Examples of intra-individual homogeneity and heterogeneity in IHC marker expression of DCIS lesions. In an example of a homogeneous case (left), expression of all markers is similar across DCIS lesions. All markers within this case were classified as
Mary B. Daly (196724), Carolyn M. Slater (590403), Kathy Q. Cai (590404), Karthik Devarajan (215762), Hong Wu (105254), Arthur Patchefsky (590405), Xiaowei Chen (200607), Dana Pape-Zambito (590402), Zhengyu Jiang (211582)   +8 more
core   +1 more source

Can Mammography and Magnetic Resonance Imaging Predict the Preoperative Size and Nuclear Grade of Pure Ductal Carcinoma In Situ?

Diagnostics
Background/Objectives: Thirty to fifty percent of ductal carcinoma in situ (DCIS) cases are high-grade and at risk of progressing to invasive carcinoma. The most important treatment-related risk factor for recurrence is the presence of residual DCIS. The
Hülya Çetin Tunçez, Merve Gürsoy Bulut, Zehra Hilal Adıbelli, Ahmet Bozer, Bülent Ahmet Kart, Demet Kocatepe Çavdar   +5 more
doaj   +1 more source

Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients.

, 2014
The heterogeneity among multiple ductal carcinoma in situ (DCIS) lesions within the same patient also diagnosed with invasive ductal carcinoma (IDC) has not been well evaluated, leaving research implications of intra-individual DCIS heterogeneity yet to ...
Mary B Daly, Mary B. Daly (196724), Carolyn M Slater, Kathy Q Cai, Kathy Q. Cai (590404), Arthur Patchefsky, Dana Pape-Zambito, Hong Wu (105254), Dana Pape-Zambito (590402), Zhengyu Jiang, Hong Wu, Carolyn M. Slater (590403), Karthik Devarajan, Karthik Devarajan (215762), Xiaowei Chen, Arthur Patchefsky (590405), Xiaowei Chen (200607), Zhengyu Jiang (211582)   +17 more
core   +1 more source

Comparison of Metabolites Obtained by HR-MAS 1H NMR Spectroscopy Between Pure DCIS and DCIS Accompanying Invasive Carcinoma.

, 2016
Comparison of Metabolites Obtained by HR-MAS 1H NMR Spectroscopy Between Pure DCIS and DCIS Accompanying Invasive Carcinoma.
Hyeon-Man Baek (294156), Jeong Hyun Lee (409520), Suhkmann Kim (294158), Ji Hoon Shin (3080226), Gyungyub Gong (91324), Ye Eun Shim (3080229), Woo Jung Choi (3080220), Siwon Kim (1876051), Joo Hee Cha (3080214), Dahye Yoon (2549869), Hee Jin Lee (594598), Hee Jung Shin (3080223), Hak Hee Kim (791253), Eun Young Chae (3080217)   +13 more
core   +1 more source

B cells and energy metabolism in HER2-positive DCIS: insights into breast cancer progression from spatial-omics analyses

Breast Cancer Research
During breast tumor progression, the transition from ductal carcinoma in situ (DCIS) to invasive breast cancer is a critical step with large implications for prognosis. However, the mechanisms of invasion are still largely unknown.
Helga Bergholtz, Jens Henrik Norum, Tonje Gulbrandsen Lien, Martina Landschoof Skrede, Øystein Garred, Therese Sørlie   +5 more
doaj   +1 more source

S100A7 (Psoriasin), highly expressed in Ductal Carcinoma (DCIS), is regulated by IFN-gamma in mammary epithelial cells-1

, 2011
Copyright information:Taken from "S100A7 (Psoriasin), highly expressed in Ductal Carcinoma (DCIS), is regulated by IFN-gamma in mammary epithelial cells"http://www.biomedcentral.com/1471-2407/7/205BMC Cancer 2007;7():205-205.Published online 6 Nov ...
Anna Bylander (83715), Maria Yhr (83716), Charlotta Enerbäck (83717), Stina Petersson (83714)   +3 more
core   +1 more source